New Trial Shows Effectiveness of BPaL Regimen for Highly Drug-Resistant TB
TB Alliance’s ZeNix trial in South Africa and Eastern Europe sought to optimize the 6-month treatment regimen with reduced exposure to the drug linezolid. Read Here.
Recent Posts
See AllAt the International AIDS Conference in Montreal, civil society and activist organizations launched a new campaign inspired by the legacy of the late Dr. Paul Farmer calling for the “staff, stuff, spa
30
The Project to Accelerate New Treatments for Tuberculosis (PAN-TB) collaboration announced today the execution of a joint development agreement (JDA) supporting the progression of two investigational
30
A massive new analysis of Mycobacterium tuberculosis isolates from around the world provides an "unparalleled view" of the mechanisms behind drug-resistant tuberculosis (TB). The analysis, described i
20